Paulson, Loeb, Viking Suffer As Allergan-Pfizer Merger Falls Through – ValueWalk Premium
Allergan-Pfizer Merger

Paulson, Loeb, Viking Suffer As Allergan-Pfizer Merger Falls Through

Allergan's stock nosedived on Monday, falling more than 20% as soon as the U.S Treasury announced its decision to pursue stricter rules to curb tax inversion mergers and buyouts. The Dublin-based pharmaceutical company was set to merge with U.S.-based Pfizer Inc. The Treasury's announcement on Monday broke down the $160 billion AGN-PFE merger which was set to make the world's largest pharmaceutical company, had it happened . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0